Drug sales up 5% in year to December 2006

26 February 2007

Retail pharmacy drug sales in 13 major markets grew 5% overall at both constant exchange rates and in US$ terms, during the 12 months to December 2006, reaching $388.28 billion, reports IMS Health's Retail Drug Monitor. The rate of increase remains unchanged since April 2006 (Marketletters passim), although the constant exchange rate value has fluctuated from 3% to 5% since August last year.

Brazil, the fastest-growing market, halted its relative slow-down from 36% annual growth for the year ending July 2006, staying at 24% for both November and December, at $8.37 billion, while Mexico dipped to 8% at $8.10 billion and Argentina held a 12% rise for $2.29 billion. Overall, the leading players in the Latin American market grew 15%, from 17% in November 2006.

USA lead grows in IMS markets

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight